This early-stage study tested the safety of a new pain medication called SBS-1000 in healthy adults. Researchers gave increasing doses to 48 participants to see how their bodies handled the drug and to check for side effects. The goal was to determine safe dosage levels before te…
Phase: PHASE1 • Sponsor: Sparian Biosciences, Inc • Aim: Symptom relief
Last updated Apr 02, 2026 05:26 UTC